Daman Implements First Full PBM System

BMI View: While emerging pharmaceutical markets are a fantastic growth story, higher drug prices in emerging markets are only going to last for so long. Eventually, price controls in emerging markets will follow those used in the developed world, leading to higher prices, especially in markets where the state or health insurance schemes pay for a large proportion of healthcare, such as in the countries of the Gulf Cooperation

To read the full article, please choose one of the following options: